Abstract
Urinary stones are predominantly crystalline and the precipitation of uro-crystals must obey the physical-chemical principles applicable to crystallization in a broader sense. Key amongst these is the requirement for supersaturation to be generated, providing the necessary thermodynamic driving force for crystallization. The three main processes of nucleation, growth, and aggregation are all dependent on the degree of supersaturation. Nucleation of uro-crystals will be heterogeneous (occurring at a surface) and can only be sustained at a supersaturation above the equilibrium condition. Once nucleation has occurred, growth and aggregation can proceed until a saturated equilibrium is achieved, although in the continuous flow of the urinary system the supersaturation may be maintained by replenishment with fresh solute. A new crystallization process has recently been recognized involving the ordered clustering of nanocrystals, which brings together elements of nucleation, growth, and aggregation. The relevance of this to uro-crystallization is not yet clear. Of established significance is the presence of crystallization inhibitors and promoters in urine. These might act through changes in supersaturation or directly at the interface between crystals and solution or crystals and their nucleating substrate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- a:
-
activity
- Δa :
-
activity driving force (supersaturation)
- A :
-
pre-exponential factor (in Arrhenius reaction rate equation)
- c :
-
concentration
- Δc :
-
concentration driving force (supersaturation)
- CaOx:
-
calcium oxalate (crystalline)
- ΔG :
-
Gibbs energy change
- ΔG het :
-
Gibbs energy change for heterogeneous nucleation
- ΔG hom :
-
Gibbs energy change for homogeneous nucleation
- ΔG s :
-
Gibbs energy change for production of new crystal surface
- ΔG v :
-
Gibbs energy change for production of new crystal volume
- ΔG crit :
-
Gibbs energy change for production of a critical nucleus
- g :
-
growth rate
- I :
-
ionic strength
- J :
-
nucleation rate
- k :
-
growth rate constant
- k sp :
-
solubility product
- k :
-
Boltzmann constant
- FP :
-
formation product
- L :
-
particle size
- L crit :
-
size of critical nucleus
- M :
-
strength factor of aggregation bridge
- ML:
-
metastable limit
- N:
-
Avogadro’s number
- n :
-
growth rate reaction order
- pK a :
-
-log (acid dissociation constant)
- r :
-
radius
- r crit :
-
radius of critical nucleus
- R :
-
gas constant
- R agg :
-
aggregation rate
- R coll :
-
aggregate collision rate
- R con :
-
aggregate consolidation rate
- R disp :
-
aggregate dispersion rate
- S :
-
supersaturation ratio
- T :
-
absolute temperature
- v m :
-
molecular volume
- (x):
-
concentration of species x
- [x]:
-
activity of species x
- z :
-
valency
- α :
-
volume shape factor
- β :
-
surface shape factor
- γ :
-
activity coefficient
- γ Ss :
-
interfacial energy (between substratum and solution phase)
- γ cs :
-
interfacial energy (between crystal and solution phase)
- γ Sc :
-
interfacial energy (between substratum and crystal phase)
- θ :
-
contact angle
- μ 0 :
-
chemical potential at the standard state
- μ :
-
chemical potential
- Δμ :
-
thermodynamic driving force
- σ :
-
relative supersaturation
- Ï„ :
-
induction time
- Φ :
-
reaction affinity (positive form of Δμ)
- Φ /N :
-
reaction affinity per molecule
- Ï• :
-
heteronucleation factor
- Ψ :
-
aggregation efficiency factor
- c:
-
crystals
- eq:
-
equilibrium
- s:
-
solution
- S:
-
substratum
References
Sohnel O, Garside J. Precipitation. In: Basic Principles and Industrial Applications. Oxford: Butterworth-Heinemann Ltd; 1992.
Mullin JW. Crystallization. 3rd ed. Oxford: Butterworth-Heinemann Ltd; 1993.
Finlayson B. Physicochemical aspects of urolithiasis. Kidney Int. 1978;13:344–360.
Wu WJ, Nancollas GH. Determination of interfacial tension from crystallization and dissolution data: a comparison with other methods. Adv Coll Interface Sci. 1999;79:229–279.
Wang LJ, Nancollas GH. Calcium orthophosphates: crystallization and dissolution. Chem Rev. 2008;108:4628–4669.
Kok D. Clinical implications of physicochemistry of stone formation. Endocrinol Metab Clin N Am. 2002;31:855.
Kavanagh JP. Supersaturation and renal precipitation: the key to stone formation? Urol Res. 2006;34:81–85.
Kavanagh JP. Methods for the study of calcium-oxalate crystallization and their application to urolithiasis research. Scan Microsc. 1992;6:685–705.
Kavanagh JP. In vitro calcium oxalate crystallization methods. Urol Res. 2006;34:139–145.
Streit J, Tran-Ho LC, Konigsberger E. Solubility of the three calcium oxalate hydrates in sodium chloride solutions and urine-like liquors. Monatshefte Chem. 1998;129:1225–1236.
Pak CYC, Holt K. Nucleation and growth of brushite and calcium-oxalate in urine of stone-formers. Metab-Clin Exp. 1976;25:665–673.
Pak CYC, Rodgers K, Poindexter JR, et al. New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate. J Urol. 2008;180:1532–1537.
Werness PG, Brown CM, Smith LH, et al. Equil2 – a basic computer-program for the calculation of urinary saturation. J Urol. 1985;134:1242–1244.
Laube N, Rodgers A, Allie-Hamdulay S, et al. Calcium oxalate stone formation risk – a case of disturbed relative concentrations of urinary components. Clini Chem Lab Med. 2008;46:1134–1139.
Rodgers A, Allie-Hamdulay S, Jackson G. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor. Nephrol Dial Transplant. 2006;21:361–369.
Grases F, Villacampa AI, Sohnel O, et al. Phosphate composition of precipitates from urine-like liquors. Crystal Res Technol. 1997;32:707–715.
Rodgers AL, Allie-Hamdulay S, Jackson GE. JESS: what can it teach us? Renal Stone Dis. 2007;900:183–191.
Pak CYC, Moe OW, Maalouf NM, et al. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite. J Urol. 2009;181:1423–1428.
Tiselius HG. Aspects on estimation of the risk of calcium-oxalate crystallization in urine. Urol Int. 1991;47:255–259.
Tiselius HG, Ferraz RRN, Heilberg IP. An approximate estimate of the ion-activity product of calcium oxalate in rat urine. Urol Res. 2003;31:410–413.
Tiselius HG. A simplified estimate of the ion-activity product of calcium-phosphate in urine. Eur Urol. 1984;10:191–195.
Ogawa Y, Hatano T. Comparison of the Equil2 program and other methods for estimating the ion-activity product of urinary calcium oxalate: a new simplified method is proposed. Int J Urol. 1996;3:383–385.
Grover PK, Marshall VR, Ryall RL. Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: Implications for calcium oxalate stone genesis. Chem Biol. 2003;10:271–278.
Grover PK, Ryall RL. Critical appraisal of salting-out and its implications for chemical and biological sciences. Chem Rev. 2005;105:1–10.
Nancollas GH, Wu WJ. Biomineralization mechanisms: a kinetics and interfacial energy approach. J Crystal Growth. 2000;211:137–142.
Lonsdale K. Epitaxy as a growth factor in urinary calculi and gallstones. Nature. 1968;217:56–.
Grases F, Costa-Bauza A, Ramis M, et al. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta. 2002;322:29–36.
Kavanagh JP. Enlargement of a lower pole calcium oxalate stone: a theoretical examination of the role of crystal nucleation, growth, and aggregation. J Endourol. 1999;13:605–610.
Sohnel O, Grases F, March JG. Experimental-technique simulating oxalocalcic renal stone generation. Urol Res. 1993;21:95–99.
Wu WJ, Gerard DE, Nancollas GH. Nucleation at surfaces: the importance of interfacial energy. J Am Soc Nephrol. 1999;10:S355–S358.
El-Shall H, Jeon JH, Abdel-Aal EA, et al. A study of primary nucleation of calcium oxalate monohydrate: II. Effect of urinary species. Crystal Res Technol. 2004;39:222–229.
Curreri PA, Onoda G, Finlayson B. A comparative appraisal of adsorption of citrate on whewellite seed crystals. J Crystal Growth. 1981;53:209–214.
Nancollas GH, Gardner GL. Kinetics of crystal growth of calcium oxalate monohydrate. J Crystal Growth. 1974;21:267–276.
Nancollas GH, Smesko SA, Campbell AA, et al. Physical-chemical studies of calcium-oxalate crystallization. Am J Kidney Dis. 1991;17:392–395.
Zauner R, Jones AG. Determination of nucleation, growth, agglomeration and disruption kinetics from experimental precipitation data: the calcium oxalate system. Chem Eng Sci. 2000;55:4219–4232.
Skrtic D, Markovic M, Komunjer L, et al. Precipitation of calcium oxalates from high ionic-strength solutions. 1. Kinetics of spontaneous precipitation of calcium-oxalate trihydrate. J Crystal Growth. 1984;66:431–440.
Gvozdev NV, Petrova EV, Chernevich TG, et al. Atomic force microscopy of growth and dissolution of calcium oxalate monohydrate (COM) crystals. J Crystal Growth. 2004;261:539–548.
Guo SW, Ward MD, Wesson JA. Direct visualization of calcium oxalate monohydrate crystallization and dissolution with atomic force microscopy and the role of polymeric additives. Langmuir. 2002;18:4284–4291.
Finlayson B. Concept of a continuous crystallizer – its theory and application to in-vivo and in-vitro urinary-tract models. Investig Urol. 1972;9:258–263.
Robertson WG, Scurr DS, Bridge CM. Factors influencing the crystallization of calcium-oxalate in urine – critique. J Crystal Growth. 1981;53:182–194.
Zhang JW, Nancollas GH. Kink density and rate of step movement during growth and dissolution of an AB crystal in a nonstoichiometric solution. J Colloid Interface Sci. 1998;200:131–145.
Chernov AA, Rashkovich LN, Vekilov PG. Steps in solution growth: dynamics of kinks, bunching and turbulence. J Crystal Growth. 2005;275:1–18.
Chernov AA, Petrova E, Rashkovich LN. Dependence of the CaOx and MgOx growth rate on solution stoichiometry. Non-Kossel crystal growth. J Crystal Growth. 2006;289:245–254.
Kavanagh JP, Jones L, Rao PN. Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio. Urol Res. 1999;27:231–237.
Pak CYC, Adams-Huet B, Poindexter JR, et al. Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int. 2004;66:2032–2037.
Kok DJ, Khan SR. Calcium-oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int. 1994;46:847–854.
Saw NK, Rao PN, Kavanagh JP. A nidus, crystalluria and aggregation: key ingredients for stone enlargement. Urol Res. 2008;36:11–15.
Falope GO, Jones AG, Zauner R. On modelling continuous agglomerative crystal precipitation via Monte Carlo simulation. Chem Eng Sci. 2001;56:2567–2574.
Bramley AS, Hounslow MJ, Ryall RL. Aggregation during precipitation from solution: A method for extracting rates from experimental data. J Coll Interface Sci. 1996;183:155–165.
Liew TL, Barrick JP, Hounslow MJ. A micro-mechanical model for the rate of aggregation during precipitation from solution. Chem Eng Technol. 2003;26:282–285.
David R, Espitalier F, Cameirao A, et al. Developments in the understanding and modeling of the agglomeration of suspended crystals in crystallization from solution. KONA. 2001;21:40–53.
Andreassen JP, Hounslow MJ. Growth and aggregation of vaterite in seeded-batch experiments. AlChE J. 2004;50:2772–2782.
Linnikov OD. Mechanism of aggregation and intergrowth of crystals during bulk crystallization from solutions. Crystal Res Technol. 2008;43:1268–1277.
Ryall RL. The future of stone research: rummagings in the attic, Randall’s plaque, nanobacteria, and lessons from phylogeny. Urol Res. 2008;36:77–97.
Navrotsky A. Energetic clues to pathways to biomineralization: Precursors, clusters, and nanoparticles. Proc Natl Acad Sci USA. 2004;101:12096–12101.
Colfen H, Antonietti M. Mesocrystals: Inorganic superstructures made by highly parallel crystallization and controlled alignment. Angew Chem Int Ed. 2005;44:5576–5591.
Niederberger M, Colfen H. Oriented attachment and mesocrystals: Non-classical crystallization mechanisms based on nanoparticle assembly. Phys Chem Chem Phys. 2006;8:3271–3287.
Xu AW, Ma YR, Colfen H. Biomimetic mineralization. J Mater Chem. 2007;17:415–449.
Kulak AN, Iddon P, Li YT, et al. Continuous structural evolution of calcium carbonate particles: A unifying model of copolymer-mediated crystallization. J Am Chem Soc. 2007;129:3729–3736.
Webber D, Chauvet MC, Ryall RL. Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects. Urol Res. 2005;33:273–284.
Sandersius S, Rez P. Morphology of crystals in calcium oxalate monohydrate kidney stones. Urol Res. 2007;35:287–293.
Dorian HH, Rez P, Drach GW. Evidence for aggregation in oxalate stone formation: Atomic force and low voltage scanning electron microscopy. J Urol. 1996;156:1833–1837.
Ryall RL, Chauvet MC, Grover PK. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int. 2005;96:654–663.
Ryall RL, Cook AF, Thurgood LA, et al. Macromolecules relevant to stone formation. Renal Stone Disease. 2007;900:129–140.
Touryan LA, Lochhead MJ, Marquardt BJ, et al. Sequential switch of biomineral crystal morphology using trivalent ions. Nat Mater. 2004;3:239–243.
Fasano JM, Khan SR. Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: An in vitro study. Kidney Int. 2001;59:169–178.
Khan SR. Heterogeneous nucleation of calcium-oxalate crystals in mammalian urine. Scan Microsc. 1995;9:597–616.
Guan XY, Wang LJ, Dosen A, et al. An understanding of renal stone development in a mixed oxalate-phosphate system. Langmuir. 2008;24:7058–7060.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Kavanagh, J.P. (2010). Physicochemical Aspects of Uro-crystallization and Stone Formation. In: Rao, N., Preminger, G., Kavanagh, J. (eds) Urinary Tract Stone Disease. Springer, London. https://doi.org/10.1007/978-1-84800-362-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-84800-362-0_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84800-361-3
Online ISBN: 978-1-84800-362-0
eBook Packages: MedicineMedicine (R0)